“We use cookies on this website to enhance your user experience and to personalise content. By clicking any link or continuing to use our Website you agree to our cookies as per our Privacy Policy. Read More” Ok, I agree

Phentermine Hydrochloride (Phentermine Hydrochloride)

Trade Name : phentermine hydrochloride

Eon Labs, Inc.

CAPSULE

Strength 15 mg/1

PHENTERMINE HYDROCHLORIDE Appetite Suppression [PE],Increased Sympathetic Activity [PE],Sympathomimetic Amine Anorectic [EPC]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Phentermine Hydrochloride (Phentermine Hydrochloride) which is also known as phentermine hydrochloride and Manufactured by Eon Labs, Inc.. It is available in strength of 15 mg/1 per ml. Read more

Phentermine Hydrochloride (Phentermine Hydrochloride) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • Phentermine hydrochloride capsules are indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index u226530 kg/m2, or u226527 kg/m in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia).
  • Below is a chart of body mass index (BMI) based on various heights and weights.
  • BMI is calculated by taking the patientu2019s weight, in kilograms (kg), divided by the patientu2019s height, in meters (m), squared. Metric conversions are as follows: pounds u00f7 2.2 = kg; inches x 0.0254 = meters.
  • BODY MASS INDEX (BMI), kg/mn
  • The limited usefulness of agents of this class, including phentermine, should be measured against possible risk factors inherent in their use such as those described below.
  • Phentermine hydrochloride is a sympathomimetic amine anorectic indicated as a short-term adjunct (a few weeks) in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index u226530 kg/m, or u226527 kg/m in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia). n
  • The limited usefulness of agents of this class, including phentermine hydrochloride, should be measured against possible risk factors inherent in their use. n
  • No data
  • Capsules containing 15 mg or 30 mg phentermine hydrochloride (equivalent to 12 mg or 24 mg phentermine base, respectively).
  • 15 mg capsules: grey/yellow opaque body, filled with white to off-white powder, imprinted u201cu201d in black ink.
  • 30 mg capsules: yellow opaque cap and body, filled with white to off-white powder, imprinted u201cu201d in black ink.
  • 30 mg capsules: blue/clear, blue/white pellets, imprinted u201cu201d in black ink.
  • u2022
  • (3)
  • No data
  • 4n- 8.1
  • 4n- 8.3
  • No data
  • The following adverse reactions are described, or described in greater detail, in other sections:
  • The following adverse reactions to phentermine have been identified:
  • Cardiovascular
  • Primary pulmonary hypertension and/or regurgitant cardiac valvular disease, palpitation, tachycardia, elevation of blood pressure, ischemic events.
  • Central Nervous System
  • Overstimulation, restlessness, dizziness, insomnia, euphoria, dysphoria, tremor, headache, psychosis.
  • Gastrointestinal
  • Dryness of the mouth, unpleasant taste, diarrhea, constipation, other gastrointestinal disturbances.
  • Allergic
  • Urticaria.
  • Endocrine
  • Impotence, changes in libido.
  • Adverse events have been reported in the cardiovascular, central nervous, gastrointestinal, allergic, and endocrine systems. n
  • To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or n
  • No data
  • 4n- 7.1
  • No data
  • 4n- 8.3
  • No data
  • The least amount feasible should be prescribed or dispensed at one time in order to minimize the possibility of overdosage.
  • Phentermine hydrochloride is a sympathomimetic amine anorectic. Its chemical name is u03b1,u03b1,dimethylphenethylamine hydrochloride. The structural formula is as follows:
  • CHN u2022 HCl M.W. 185.7
  • Phentermine hydrochloride is a white, odorless, hygroscopic, crystalline powder which is soluble in water and lower alcohols, slightly soluble in chloroform and insoluble in ether.
  • Phentermine hydrochloride capsules, USP are available as an oral capsule containing 15 mg or 30 mg of phentermine hydrochloride (equivalent to 12 mg or 24 mg of phentermine base).
  • a) powder-filled capsules containing 15 mg phentermine hydrochloride (equivalent to 12 mg phentermine) or 30 mg phentermine hydrochloride (equivalent to 24 mg phentermine) and inactive ingredients: corn starch, gelatin, lactose monohydrate, magnesium stearate, silicon dioxide and sodium lauryl sulfate and
  • b) pellet-filled capsules containing 30 mg phentermine hydrochloride (equivalent to 24 mg phentermine) and inactive ingredients: corn starch, gelatin, pharmaceutical glaze, povidone, silicon dioxide, sodium lauryl sulfate and sucrose.
  • In addition, the 15 mg capsules contain FD&C blue No. 1, FD&C red No. 3, D&C yellow No. 10, FD&C red No. 40, titanium dioxide; the yellow 30 mg capsules contain FD&C red No. 3, D&C yellow No. 10, titanium dioxide; and the blue/clear 30 mg capsules contain FD&C blue No. 1, D&C red No. 28.
  • No data
  • Studies have not been performed with phentermine to determine the potential for carcinogenesis, mutagenesis or impairment of fertility.
  • In relatively short-term clinical trials, adult obese subjects instructed in dietary management and treated with u201canorecticu201d drugs lost more weight on the average than those treated with placebo and diet.
  • The magnitude of increased weight loss of drug-treated patients over placebo-treated patients is only a fraction of a pound a week. The rate of weight loss is greatest in the first weeks of therapy for both drug and placebo subjects and tends to decrease in succeeding weeks. The possible origins of the increased weight loss due to the various drug effects are not established. The amount of weight loss associated with the use of an u201canorecticu201d drug varies from trial to trial, and the increased weight loss appears to be related in part to variables other than the drugs prescribed, such as the physician-investigator, the population treated and the diet prescribed. Studies do not permit conclusions as to the relative importance of the drug and non-drug factors on weight loss.
  • The natural history of obesity is measured over several years, whereas the studies cited are restricted to a few weeksu2019 duration; thus, the total impact of drug-induced weight loss over that of diet alone must be considered clinically limited.
  • Phentermine hydrochloride capsules, USP for oral administration, are available as:
  • 15 mgn- E882
  • 30 mgn- E647
  • 30 mgn- E5000
  • Store at 20u00b0 to 25u00b0C (68u00b0 to 77u00b0F) [see USP Controlled Room Temperature].
  • Protect from moisture.
  • Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).
  • Keep out of the reach of children.
  • Patients must be informed that phentermine hydrochloride is a (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity, and that coadministration of phentermine with other drugs for weight loss is not recommended n n
  • Patients must be instructed on how much phentermine to take, and when and how to take it n .
  • Advise pregnant women and nursing mothers not to use phentermine n .
  • Patients must be informed about the risks of use of phentermine (including the risks discussed in Warnings and Precautions), about the symptoms of potential adverse reactions and when to contact a physician and/or take other action. The risks include, but are not limited to:
  • See also, for example, n .
  • The patients must also be informed about
  • Tell patients to keep phentermine in a safe place to prevent theft, accidental overdose, misuse or abuse. Selling or giving away phentermine may harm others and is against the law.
  • Manufactured for
  • Sandoz Inc.
  • Princeton, NJ 08540
  • Manufactured by
  • Epic Pharma, LLC
  • Laurelton, NY 11413
  • OS7330
  • Rev. 04/17
  • MF5000REV04/17
  • NDC
  • Phentermine Hydrochloride Capsules, USP CIV
  • 15 mg
  • Grey/Yellow
  • Rx only
  • 100 Capsules
  • Sandoz
  • NDC
  • Phentermine Hydrochloride Capsules, USP CIV
  • 30 mg
  • Blue/Clear
  • Rx only
  • 100 Capsules
  • Sandoz
  • NDC
  • Phentermine Hydrochloride Capsules, USP CIV
  • 30 mg
  • Yellow
  • Rx only
  • 100 Capsules
  • Sandoz

Similar Products

Desogestrel And Ethinyl Estradiol (Emoquette)

Desogestrel And Ethinyl Estradiol (Emoquette)

Manufacturer: REMEDYREPACK INC.

Presentation: KIT

Strength:

Pack Size:

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET

Strength: 2.5; .025 mg/1; mg/1

Pack Size:

Fluoxetine Hydrochloride (Fluoxetine)

Fluoxetine Hydrochloride (Fluoxetine)

Manufacturer: REMEDYREPACK INC.

Presentation: CAPSULE

Strength: 40 mg/1

Pack Size:

Metoprolol Succinate (Metoprolol Succinate)

Metoprolol Succinate (Metoprolol Succinate)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET, EXTENDED RELEASE

Strength: 25 mg/1

Pack Size:

Losartan Potassium (Losartan Potassium)

Losartan Potassium (Losartan Potassium)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET, FILM COATED

Strength: 25 mg/1

Pack Size:

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71246 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Get Price

Are you an existing customer or a vendor of GNH India? Log in here to

View your Transaction
COMPANY
SERVICES
QUICK LINKS
CONTACT US
Registered Office Address:

Unit # G- 14, 15, 16, 17, Ground Floor, Prabhadevi Industrial Estate, Enterprises Industrial Premises, 408, Veer Sawarkar Road, Prabhadevi,
Mumbai 400025 India

US Office Address:

GNH Pharmaceuticals USA LLC,
Suite E # 499, 1235 EAST BLVD,
Charlotte, NC, 28203, U.S.A
TEL: +1 704 557 0412

Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.